Nov 26, 2014 at 19:17 | Source: PTI
NR Narayana Murthy said that software industry has overtaken PSUs as biggest job creator in the country with about 32 lakh-strong workforce and further addition of two lakh new jobs a year.
Nov 26, 2014 at 15:22 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com recommends buying Ambuja Cements, Sun Pharma and Mindtree.
Nov 26, 2014 at 14:33 | Source: Moneycontrol.com
Angel Broking has maintained a neutral rating on Sun Pharmaceutical Industries, in its November 14, 2014 research report.
Nov 26, 2014 at 11:01 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips, pharma stocks like Glenmark Pharma, Sun Pharma, Cipla, Biocon and Dr Reddys Lab's will be getting astrological support.
Nov 25, 2014 at 11:05 | Source: CNBC-TV18
Sanjay Dutt, Director at Quantum Securities is of the view that one may prefer Sun Pharmaceutical Industries.
Nov 25, 2014 at 10:16 | Source: Moneycontrol.com
The brokerage sees limited scope for re-rating given high valuations of stocks in the automobiles, banking, consumer and pharmaceutical sectors.
Nov 25, 2014 at 10:07 | Source: Moneycontrol.com
Brokerage house KRChoksey has recommended a hold rating on Sun Pharmaceutical Industries with a target price of Rs 915 per share in its November 14, 2014 research report.
Nov 24, 2014 at 14:15 | Source: Moneycontrol.com
Sun Pharmaceutical Industries Ltd has informed BSE that the Hon'ble High Court of Gujarat at Ahmedabad, at its hearing held on November 14, 2014, has sanctioned the Scheme of Arrangement in the nature of Merger of Ranbaxy Laboratories Limited with Sun Pharmaceutical Industries Limited.
Nov 24, 2014 at 10:30 | Source: CNBC-TV18
Parag Thakkar of HDFC Securities recommends going long in Cipla.
Nov 24, 2014 at 09:47 | Source: CNBC-TV18
Watch the interview of Parag Thakkar of HDFC Securities with Latha Venkatesh & Sonia Shenoy on CNBC-TV18, in which he shared his readings and outlook on market and specific stocks.